Clinical Use of the Low-Molecular-Weight Heparins in Cancer Patients: Focus on the Improved Patient Outcomes
Thrombosis · 2011
DOI: 10.1155/2011/530183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis, 2011. Verfasst von Bo H Chao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison WI 53792, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Kathleen Reader Memorial Research Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Patients with malignant neoplastic diseases represent a high-risk population relative to thromboembolic disease. With the advent of improved and accessible diagnostic technology, for example, ultrasound and/or spiral CT scans, timely diagnosis of venous thromboembolic events (VTE) is readily accomplished. The introduction of low-molecular-weight heparin (LMWH) approximately two decades ago (in contrast to unfractionated heparin and vitamin K antagonists) has provided a class of agents with a favorable therapeutic index. In the review to follow, the literature regarding the use of LMWH in oncologic patient populations is summarized. Topics addressed include prophylaxis, and treatment as well as consideration of the potential anti-neoplastic properties of this class of drugs.
Autor:innen und Institutionen
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison WI 53792, USA.
Förderung
- Kathleen Reader Memorial Research Fund
Zitieren
APA
Chao, B. H., Lepeak, L., Leal, T., & Robins, H. I. (2011). Clinical Use of the Low-Molecular-Weight Heparins in Cancer Patients: Focus on the Improved Patient Outcomes. Thrombosis. https://doi.org/10.1155/2011/530183
Vancouver
Chao BH, Lepeak L, Leal T, Robins HI. Clinical Use of the Low-Molecular-Weight Heparins in Cancer Patients: Focus on the Improved Patient Outcomes. Thrombosis. 2011. doi:10.1155/2011/530183
BibTeX
@article{Chao2011,
author = {Chao, Bo H and Lepeak, Lisa and Leal, Ticiana and Robins, H Ian},
title = {Clinical Use of the Low-Molecular-Weight Heparins in Cancer Patients: Focus on the Improved Patient Outcomes},
journal = {Thrombosis},
year = {2011},
doi = {10.1155/2011/530183}
}
EUVIMED